Filing Details

Accession Number:
0000884905-17-000076
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-08 14:17:18
Reporting Period:
2016-11-07
Accepted Time:
2017-11-08 14:17:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884905 Praxair Inc PX Industrial Inorganic Chemicals (2810) 061249050
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1119504 W Raymond Leboeuf C/O Praxair, Inc.
39 Old Ridgebury Road
Danbury CT 06810-5113
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-07 6,550 $61.47 16,697 No 4 M Direct
Common Stock Disposition 2016-11-07 6,550 $117.26 10,147 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-11-07 6,550 $0.00 6,550 $61.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-02-27 2017-02-27 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $83.89 2009-02-26 2018-02-26 3,885 3,885 Direct
Common Stock Stock Option (right to buy) $60.92 2010-02-24 2019-02-24 4,600 4,600 Direct
Common Stock Deferred Stock $0.00 48,566 48,566 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-02-26 3,885 3,885 Direct
2019-02-24 4,600 4,600 Direct
48,566 48,566 Direct
Footnotes
  1. The $117.263 price reported is the weighted average sale price. The sale prices ranged from $117.258 to $117.288 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
  2. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
  3. Conversion to Praxair Common Stock is on a 1-for-1 basis.
  4. Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service.